Skip to main content
OpenTrials
Completed

NCT Number: NCT01398813

X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey

In this survey of X-Lined Hypohidrotic Ectodermal Dysplasia (XLHED) carrier females, Edimer proposes to review responses to an XLHED Carrier Outlook toward Reproduction Survey in order to understand attitudes toward reproduction, potential treatments and genetic testing in order to improve the understanding of the decisions that XLHED carrier females make regarding their reproductive future.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The full survey is available here: https://www.surveymonkey.com/s/X-CORS

For more questions or more details you may contact the Principal Investigator, Carrie Milliard: [email protected] or 207-662-6712

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Provide signed informed consent;
  • 18 years of age or older
  • Females with:
  • the clinical characteristics of HED, including at least two of the following characteristics:
  • clinical signs and symptoms of HED:
  • a history of decreased sweating;
  • abnormal teeth (fewer permanent teeth, teeth are smaller than average and often have conical crowns);
  • sparseness of scalp and body hair;
  • AND
  • a clinical diagnosis from a healthcare professional;
  • or at least one HED affected family member
  • OR genetically confirmed HED or XLHED;

Treatment and study plan

Primary outcomes

  1. To study the outlook of XLHED carrier females toward reproduction, potential XLHED treatments and genetic testing.

    Time frame: study day 1

    Survey results will be collected during the 1 day of subject involvement.

Sponsors and collaborators

Lead sponsor

Edimer Pharmaceuticals

Industry

Registry information

Official study title

Survey of X-Linked Hypohidrotic Ectodermal Dysplasia Carrier Women's Outlook Towards Reproduction, Potential XLHED Treatments and Genetic Testing

Acronym: X-CORS

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jul 21, 2011
Registry last updated
Jul 9, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.